Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 217Precursor Cell Lymphoblastic Leukemia-Lymphoma 192Lymphoma, Large B-Cell, Diffuse 173Leukemia 102Burkitt Lymphoma 91Lymphoma, Non-Hodgkin 90Lymphoma, Follicular 79Lymphoma, Mantle-Cell 53Neuroblastoma 51Hodgkin Disease 46Central Nervous System Neoplasms 43Sarcoma 37Lymphoma, B-Cell 31Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Recurrence 29Lymphoma, Large-Cell, Anaplastic 29Lymphoma, T-Cell, Peripheral 28Lymphoma, Large-Cell, Immunoblastic 27Rhabdomyosarcoma 25Neoplasms 25Multiple Myeloma 24Medulloblastoma 22Lymphoma, B-Cell, Marginal Zone 22Leukemia, Lymphocytic, Chronic, B-Cell 21Leukemia, Biphenotypic, Acute 21Brain Neoplasms 20Sarcoma, Ewing 18Retinoblastoma 18Lymphoma, T-Cell 17HIV Infections 17

Interventions

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 3Cyclophosphamide 3pembrolizumab 1fludarabine 1Vincristine 1Prednisone 1Interleukin-21 1Etoposide 1Doxorubicin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Experimental × Vincristine × Clear all
NCT03617432 2018-09-04

Chidamide Combined With CHOPE Regimen for Peripheral T-cell Lymphoma Patients

Peking University

Phase 2 Unknown
114 enrolled

Neoplasms, Experimental

Data powered by HemOnc (CC BY 4.0) Colophon âš¡